Skip to main content
NBCA

Resultaten

Ieder jaar publiceert DICA de resultaten van de registraties. Daardoor ontstaat een beeld van de kwaliteit van de zorg in Nederland. De resultaten over 2017 zijn, per registratie, te vinden in de online jaarrapportage.

De NBCA heeft daarnaast over het jaar 2017 een eigen jaarverslag uitgebracht.

Publicaties met data uit de NBCA:

Van Bommel, A., Spronk, P. E., Vrancken Peeters, M. J. T., Jager, A., Lobbes, M., Maduro, J. H., ... & Westenend, P. J. (2017). Clinical auditing as an instrument for quality improvement in breast cancer care in the Netherlands: The national NABON Breast Cancer Audit. Journal of surgical oncology115(3), 243-249. https://www.ncbi.nlm.nih.gov/pubmed/27885679

Poodt, I. G., Rots, M. L., Vugts, G., van Dalen, T., Kuijer, A., Vriens, B. E., ... & Schipper, R. J. (2018). The administration of adjuvant chemo (-immuno) therapy in the post ACOSOG-Z0011 era; a population based study. European Journal of Surgical Oncologyhttps://www.sciencedirect.com/science/article/pii/S074879831830948X

Poodt, I. G., Spronk, P. E., Vugts, G., van Dalen, T., Peeters, M. V., Rots, M. L., ... & Schipper, R. J. (2017). Trends on Axillary Surgery in Nondistant Metastatic Breast Cancer Patients Treated Between 2011 and 2015: A Dutch Population-based Study in the ACOSOG-Z0011 and AMAROS Era. Annals of Surgery. https://www.ncbi.nlm.nih.gov/pubmed/28742702

Schreuder, K., van Bommel, A. C. M., de Ligt, K. M., Maduro, J. H., Peeters, M. V., Mureau, M. A. M., & Siesling, S. (2017). Hospital organizational factors affect the use of immediate breast reconstruction after mastectomy for breast cancer in the Netherlands. The Breast34, 96-102. https://www.ncbi.nlm.nih.gov/pubmed/28552797

Spronk, P. E. R., van Bommel, A. C. M., Siesling, S., Wouters, M. W. J. M., Peeters, M. V., & Smorenburg, C. H. (2017). Variation in use of neoadjuvant chemotherapy in patients with stage III breast cancer: Results of the Dutch national breast cancer audit. The Breast36, 34-38. http://www.thebreastonline.com/article/S0960-9776(17)30572-6/fulltext

Spronk, P. E., Volders, J. H., van den Tol, P., Smorenburg, C. H., & Peeters, M. J. T. V. (2018). Breast conserving therapy after neoadjuvant chemotherapy; data from the Dutch Breast Cancer Audit. European Journal of Surgical Oncologyhttps://www.ncbi.nlm.nih.gov/pubmed/30348601

Spronk, P. E. R., de Ligt, K. M., van Bommel, A. C. M., Siesling, S., Smorenburg, C. H., & Peeters, M. V. (2018). Current decisions on neoadjuvant chemotherapy for early breast cancer: Experts’ experiences in the Netherlands. Patient education and counseling101(12), 2111-2115. https://www.ncbi.nlm.nih.gov/pubmed/30054106

Heeg, E., Schreuder, K., Spronk, P. E. R., Oosterwijk, J. C., Marang-van de Mheen, P. J., Siesling, S., ... & Audit, N. B. C. (2018). Hospital transfer after a breast cancer diagnosis: A population-based study in the Netherlands of the extent, predictive characteristics and its impact on time to treatment. European journal of surgical oncologyhttps://www.ncbi.nlm.nih.gov/pubmed/30621962